Official announcements from Aqemia or credible news sources

Aqemia Secures $38 Million Funding, Hits $100 Million Milestone for Drug Discovery Expansion in London

Dec 10, 2024, 11:17 AM

Aqemia, a Paris-based start-up focused on drug discovery, has successfully raised $38 million in a funding round led by Cathay Innovation. This new funding adds to the company's previous €30 million raised in January 2024. The capital will enable Aqemia to advance its clinical trials and expand its operations globally, beginning with a new office in London, UK. The company utilizes a unique approach that combines theoretical physics and generative AI to enhance drug discovery processes, marking a significant step in the integration of advanced technologies in pharmaceuticals.